NEW YORK (GenomeWeb News) – Metabolon announced today that it is collaborating with Harvard-Partners Center for Genetics and Genomics on developing a new test for warfarin dosing.
 
The alliance is aimed at determining whether a patient’s metabolomic profile will increase the likelihood of correctly dosing wafarin.
 
HPCGG is a joint effort between Harvard Medical School and Partners Healthcare medical system in the Boston area.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.